A rare but important adverse effect of tacrolimus in a heart transplant recipient: diabetic ketoacidosis
Heart transplantation indications in pediatric population include congenital heart diseases, cardiomyopathies and retransplants. Cardiomyopathy is the primary indication for 11 to 17 years of age. The surveillance after transplantation is a very important issue because of both the rejection r...
Saved in:
| Main Authors: | Zeynelabidin Öztürk, E Nazlı Gönç, Leman Akcan, Selman Kesici, İlker Ertuğrul, Benan Bayrakçı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2015-10-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/1282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tacrolimus Induced Diabetic Ketoacidosis Following Allogeneic Stem Cell Transplantation
by: Sanjeev Kumar Sharma, et al.
Published: (2014-08-01) -
Tacrolimus-Induced Diabetic Ketoacidosis (DKA) in Post Bone Marrow Transplant Patient
by: Omkar KALIDASRAO CHOUDHARI, et al.
Published: (2025-06-01) -
Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
by: Orhan Efe, et al.
Published: (2024-12-01) -
Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
by: Zaid Ammari, et al.
Published: (2018-01-01) -
Fatal thrombotic microangiopathy in an infant with COVID-19: a case report
by: Özlem Sarıtaş Nakip, et al.
Published: (2023-08-01)